These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18367252)

  • 61. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
    Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.
    Krug A; Rothenfusser S; Hornung V; Jahrsdörfer B; Blackwell S; Ballas ZK; Endres S; Krieg AM; Hartmann G
    Eur J Immunol; 2001 Jul; 31(7):2154-63. PubMed ID: 11449369
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro.
    Wattrang E; Berg M; Magnusson M
    Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression.
    Griebel PJ; Brownlie R; Manuja A; Nichani A; Mookherjee N; Popowych Y; Mutwiri G; Hecker R; Babiuk LA
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):11-6. PubMed ID: 16098606
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Therapeutic effects and mechanisms of CpG oligodeoxynucleotides in mice infected with Mycobacterium tuberculosis].
    Ren T; Li CY; Cai YY; Jin ML; Hu YW; Yuan ZH; Tian M; Zhao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Feb; 29(2):87-91. PubMed ID: 16677448
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PyNTTTTGT prototype oligonucleotide IMT504, a novel effective adjuvant of the FMDV DNA vaccine.
    Zhao G; Jin H; Li J; Su B; Du X; Kang Y; Wang X; Wang B
    Viral Immunol; 2009 Apr; 22(2):131-8. PubMed ID: 19327000
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C-oligodeoxynucleotide-induced IFN-alpha production.
    Berghöfer B; Haley G; Frommer T; Bein G; Hackstein H
    J Immunol; 2007 Apr; 178(7):4072-9. PubMed ID: 17371961
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs.
    Bjersing JL; Eriksson K; Tarkowski A; Collins LV
    Inflammation; 2004 Feb; 28(1):39-51. PubMed ID: 15072229
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A novel CpG ODN compound adjuvant enhances immune response to spike subunit vaccines of porcine epidemic diarrhea virus.
    Wang Y; Liu S; Li B; Sun X; Pan Q; Zheng Y; Liu J; Zhao Y; Wang J; Liu L; Du E
    Front Immunol; 2024; 15():1336239. PubMed ID: 38322258
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma.
    Gupta GK; Agrawal DK
    BioDrugs; 2010 Aug; 24(4):225-35. PubMed ID: 20623989
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CpG-ODN class C-mediated immunostimulation and its potential against Trypanosoma evansi in equines.
    Manuja A; Kumar P; Kumar R; Kumar B; Singha H; Sharma RK; Yadav SC
    Int Immunopharmacol; 2014 Oct; 22(2):366-70. PubMed ID: 25066759
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells.
    Blaas SH; Stieber-Gunckel M; Falk W; Obermeier F; Rogler G
    Clin Exp Immunol; 2009 Mar; 155(3):534-40. PubMed ID: 19220839
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
    Krug A; Towarowski A; Britsch S; Rothenfusser S; Hornung V; Bals R; Giese T; Engelmann H; Endres S; Krieg AM; Hartmann G
    Eur J Immunol; 2001 Oct; 31(10):3026-37. PubMed ID: 11592079
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides.
    Brownlie R; Zhu J; Allan B; Mutwiri GK; Babiuk LA; Potter A; Griebel P
    Mol Immunol; 2009 Sep; 46(15):3163-70. PubMed ID: 19573927
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The immune responses triggered by CpG ODNs in shrimp Litopenaeus vannamei are associated with LvTolls.
    Sun R; Wang M; Wang L; Yue F; Yi Q; Huang M; Liu R; Qiu L; Song L
    Dev Comp Immunol; 2014 Mar; 43(1):15-22. PubMed ID: 24176974
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responses.
    Yeh DW; Lai CY; Liu YL; Lu CH; Tseng PH; Yuh CH; Yu GY; Liu SJ; Leng CH; Chuang TH
    Sci Rep; 2017 Dec; 7(1):17297. PubMed ID: 29229937
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice.
    Liu Y; Luo X; Yang C; Yu S; Xu H
    Vaccine; 2011 Aug; 29(34):5778-84. PubMed ID: 21664398
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Polyethyleneimine-functionalized boron nitride nanospheres as efficient carriers for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides.
    Zhang H; Feng S; Yan T; Zhi C; Gao XD; Hanagata N
    Int J Nanomedicine; 2015; 10():5343-53. PubMed ID: 26346655
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibition of a C-rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice.
    Yang G; Wan M; Zhang Y; Sun L; Sun R; Hu D; Zhou X; Wang L; Wu X; Wang L; Yu Y
    Immunology; 2010 Dec; 131(4):501-12. PubMed ID: 20646074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.